OAA Medical Advisors
Our Medical Advisors continue to work with OAA providing education, research and support in advancing treatments for organic acidemias.
Dr. Olaf Bodamer, FACMG
Boston Children's Hospital
Dr. Bodamer has a busy clinical practice at Boston Children’s Hospital where he sees patients of all age groups with genetic disorders with a focus on lysosomal disorders and Kabuki syndrome. In addition, he is active in several areas of translational genetics and genomics research, in clinical trials and in educational and teaching activities within Harvard Medical School.
Kimberly A. Chapman, MD, PhD, FAAP, FABIM
Children's National Medical Center
Kimberly Chapman is an attending physician in Genetics and Metabolism at Children’s National and an assistant Professor of Pediatrics and Integrated Systems Biology at George Washington University in Washington DC, USA. She specializes in taking care of individuals with defects of methylation, homocysteine and propionate metabolism.
Curtis R. Coughlin II Ph.D., MS, MBE
University of Colorado Anschutz Medical Campus
Curtis Coughlin is an associate professor at the University of Colorado Anschutz Medical Campus. He completed his doctoral training with Professor Stephen Goodman and has continued to study lysine metabolism. His lab is focused on pyridoxine-dependent epilepsy (PDE-ALDH7A1) and glutaric aciduria type I (GA I).
Elaina Jurecki, MS, RD
Private Consultant For Treatments of Genetic Disorders
Elaina Jurecki is currently working as a consultant for pharmaceutical and non-profit organizations for metabolic genetic disorders. She previously worked as the Executive Director of Scientific Communications in Global Medical Affairs for the past 15 years at BioMarin Pharmaceutical Inc., responsible for publication strategy, scientific messaging, medical information, and management of congress activities.
Stephen G. Kahler, MD
UK Pediatric Specialty Clinic
Dr. Kahler received his MD degree from Duke, trained in Pediatrics at UCSD (where he learned about inborn errors from Dr. Bill Nyhan), then trained in clinical and biochemical genetics at UNC-Chapel Hill. Throughout his career he has been a clinician-educator, seeing patients and teaching, but he has always had strong affiliations with research physicians and scientists.
Mark Korson, MD
VMP Genetics, LLC
Dr. Korson graduated in medicine from the University of Toronto and completed a pediatric residency at Toronto’s Hospital for Sick Children, followed by a genetics and metabolism fellowship at Boston’s Children's Hospital. He directed the metabolic clinics at Boston Children's Hospital until 2000 and across town at Tufts Medical Center until 2014.
Mendel Tuchman, MD
Children's National Medical Center in Washington, DC.
Mendel Tuchman, MD, is the Vice Chairman for Research, Scientific Director, Children's Research Institute and Professor of Pediatrics, Biochemistry & Molecular Biology at Children's National Medical Center in Washington, DC. He is also the past-president of the Society of Inherited Metabolic Disorders. His research is supported by NIH grants, philanthropy and he holds the Mary Elizabeth McGehee Joyce Chair in Genetic Medicine at Children's Research Institute.
Keiko Ueda, MPH, RD
Kapi’olani Medical Center for Women and Children in Honolulu, HI
Keiko Ueda has worked as a Metabolic Dietitian in the University of Michigan in Ann Arbor, St. Louis Children’s Hospital, Tufts Medical Center and in Canada at BC Children’s Hospital, Vancouver. She is currently a Clinical Dietitian at Kapi’olani Medical Center for Women and Children in Honolulu, HI. where she has been privileged to learn and work with amazing and knowledgeable metabolic clinicians.
Charles P. Venditti MD, PhD
National Human Genome Research Institute
Dr. Charles P. Venditti, M.D., Ph.D., is a Sr. Investigator and the Director of the Organic Acid Research Section at the National Institutes of Health. As a clinical biochemical geneticist and laboratorian, he has developed a translational research program to study the natural history and clinical phenotype(s) of the hereditary methylmalonic acidemias (MMA), cobalamin metabolic disorders, and propionic acidemia (PA). His research group is developing gene, cell and small molecules therapeutics to treat MMA and PA.
Jerry Vockley, MD, PhD
Children's Hospital of Pittsburgh
Dr. Vockley is internationally recognized leader in the field of inborn errors of metabolism. His current research focuses on mitochondrial energy metabolism, novel therapies for disorders of fatty acid oxidation and amino acid metabolism, and population genetics of the Plain communities in the United States. He has published over 300 peer reviewed scholarly articles, is the principal investigator on four NIH grants and a co-investigator on 7 others.